Our next generation ACIX platform is capable of accommodating different sample types (serum and whole blood) and test menus catering to different market segments (lab and POC version). ACIX’s rapid turn-around time of ~20 mins, low costs combined with minimal infrastructure and manpower requirements make it suitable for low resource settings that are under-served by diagnostics labs. ACIX100 has been clinically validated for TSH. Currently, a large menu of tests, including various hormone tests and infectious diseases panels, are under development. ACIX100 is intended for fast and accurate results in lab settings. ACIX200, an evolution of ACIX100, brings cutting edge technology
ACIX100 - Features
The immunodiagnostics platform for all your needs.
arrow_drop_down
Low Sample Volume
Channels, the size of a human hair, transport fluid to the sensors – leading to low
requirement for sample and reagents.
offline_bolt
Automation
The ACIX 100 reader automates the assay steps. The cartridge can contain
all the reagents necessary for the assay.
format_size
TrapArray Technology
This allows for multiple micron sized polymer-based sensors to be
localized on the chip. Each of the sensor can perform a different assay.
cloud
Cloud Connected
ACIX 100 is connected to the cloud for easy and safe data management. Results are
available to the user via a data management dashboard.
assessment
Super Intuitive
The fully automated workflow of ACIX ensures that even entry-level or novice
technicians can handle it.
cloud_circle
Platform Technology
Designed to support a wide range of immuno-diagnostic assays making
it very suitable for novel biomarkers.
ACCURACY
High correlation to the Lab Gold Standards
Diagnostics accuracy as good as they come. ACIX100 shows very high correlation with the Lab Gold Standards and Chemiluminescence systems.
VERSATILE
Designed to support a wide range of immuno-diagnostic test panels
Currently, a menu of tests covering hormones - Thyroid-stimulating hormone (TSH), triiodothyronine (T3), Thyroxine (T4), Beta Human chorionic gonadotropin (b-hCG), Follicle Stimulating Hormone (FSH), luteinizing hormone (LH) and Prolactin (PRL) is under development. More test panels are in the pipeline under development, including cytokine assays and infectious diseases panels.
PERFORMANCE
Sensitivity
Our proprietary sensor technology allows for highly sensitive immunoassays (down to low pg/mL limits) to be performed in point-of-care settings. The dynamic range extends over 5,000:1 allowing for both high and low signal assays to be performed.
